Association of PAX4 genetic variants with oral antidiabetic drugs efficacy in Chinese type 2 diabetes patients

被引：0
作者：
M Chen
C Hu
R Zhang
F Jiang
J Wang
D Peng
S Tang
X Sun
J Yan
Y Luo
Y Bao
W Jia
机构：
[1] Shanghai Clinical Center for Diabetes,Department of Endocrinology and Metabolism
[2] Shanghai Key Clinical Center for Metabolic Disease,undefined
[3] Shanghai Key Laboratory of Diabetes Mellitus,undefined
[4] Shanghai Jiao Tong University Affiliated Sixth People’s Hospital,undefined
[5] Shanghai Diabetes Institute,undefined
来源：
The Pharmacogenomics Journal | 2014年 / 14卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The aim of this study was to investigate the association of PAX4 variants with therapeutic effect of oral antidiabetic drugs in Chinese type 2 diabtes mellitus (T2DM) patients. A total of 209 newly diagnosed T2DM patients were randomly assigned to treatment with repaglinide or rosiglitazone for 48 weeks, and the therapeutic effects were compared. In the rosiglitazone cohort, rs6467136 GA+AA carriers showed greater decrease in 2-h glucose levels (P=0.0063) and higher cumulative attainment rates of target 2-h glucose levels (Plog rank=0.0093) than GG homozygotes. In the subgroup with defective β-cell function, rs6467136 GA+AA carriers exhibited greater decrements of 2-h glucose level and improvement of homeostasis model assessment of insulin resistance (P=0.0143). Moreover, GA+AA carriers were more likely to attain the target fasting and 2-h glucose level (Plog rank=0.0091 and 0.007, respectively). However, these single-nucleotide polymorphisms showed no effect on repaglinide efficacy. In conclusion, PAX4 variant rs6467136 was associated with the therapeutic effect of rosiglitazone in Chinese T2DM patients.
引用
收藏
页码：488 / 492
页数：4
相关论文
共 122 条
[1]  
Lang D(2007)PAX genes: roles in development, pathophysiology, and cancer Biochem Pharmacol 73 1-14
[2]  
Powell SK(1997)The Pax4 gene is essential for differentiation of insulin-producing beta cells in the mammalian pancreas Nature 386 399-402
[3]  
Plummer RS(2005)Minireview: transcriptional regulation in pancreatic development Endocrinology 146 1025-1034
[4]  
Young KP(2012)Defective PAX4 R192H transcriptional repressor activities associated with maturity onset diabetes of the young and early onset-age of type 2 diabetes J Diabetes Compl 26 343-347
[5]  
Ruggeri BA(2006)The Arg121Trp variant in PAX4 gene is associated with beta-cell dysfunction in Japanese subjects with type 2 diabetes mellitus Meta Clin Exp 55 213-216
[6]  
Sosa-Pineda B(2001)A missense mutation of Pax4 gene (R121W) is associated with type 2 diabetes in Japanese Diabetes 50 2864-2869
[7]  
Chowdhury K(2007)PAX4 mutations in Thais with maturity onset diabetes of the young J Clin Endocrinol Metab 92 2821-2826
[8]  
Torres M(2005)Association of childhood type 1 diabetes mellitus with a variant of PAX4: possible link to beta cell regenerative capacity Diabetologia 48 900-905
[9]  
Oliver G(2004)PAX4 gene variations predispose to ketosis-prone diabetes Hum Mol Genet 13 3151-3159
[10]  
Gruss P(2012)Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians Nat Genet 44 67-72
12345678910